Alvotech Snags Australian Approval for Adalimumab Biosimilar – The Center for Biosimilars
Iceland-based Alvotech received regulatory approval for AVT02, its biosimilar referencing Humira (adalimumab), from the Therapeutic Goods Administration of Australia. The…